BFC Planning, Inc.’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
BFC Planning, Inc.'s IBO Position: Q2 2026 in Review
BFC Planning, Inc. held its Impact BioMedical (IBO) position steady in Q2 2026 at 17 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #3351.
BFC Planning, Inc. first reported a position in IBO in Q3 2025 and has held it in 4 quarters since. The position peaked at $145 in Q3 2025. 20 funds tracked by Wall St. Rank hold IBO as of Q2 2026.
- BFC Planning, Inc. held 17 shares of Impact BioMedical worth $100 as of Q2 2026.
- BFC Planning, Inc. left its Impact BioMedical share count unchanged in Q2 2026.
- Impact BioMedical made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3351 holding.
- BFC Planning, Inc. first reported a position in Impact BioMedical in Q3 2025 and has held it in 4 quarters since.
- BFC Planning, Inc.'s Impact BioMedical position peaked at $145 in Q3 2025.
- 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.
Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.